z-logo
open-access-imgOpen Access
Assessment of reactogenicity, safety and immunogenicity of the domestic vaccine «Encevir®» with the reduced antigenic load in the immunization of children aged 3-17 years accordingly to routine scheduled vaccination (report 2)
Author(s) -
И. В. Фельдблюм,
Фельдблюм Ирина Викторовна,
И. А. Окунева,
Окунева Ирина Александровна,
Т. В. Данилина,
Данилина Татьяна Викторовна,
M. G. Menshikova,
Меньшикова Марина Геннадьевна,
K. A Pavroz,
Павроз Ксения Андреевна,
Д. М. Трофимов,
Трофимов Денис Михайлович,
Aleksey Ershov,
Ершов Алексей Евгеньевич
Publication year - 2015
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid40871
Subject(s) - reactogenicity , immunogenicity , medicine , immunization , vaccination , vaccination schedule , antigen , virology , immunology
The article presents the results of an open comparative randomized clinical study on the assessment of the reactogenicity, safety and immunogenicity of the domestic vaccine "EntseVir®" with reduced antigenic load in immunization of children aged 3 to 17 years on the schedule for 0-60 days. The vaccine is characterized by the low reactogenicity, high safety profile and immunogenicity. On main indices, it is not inferior to foreign vaccine «FSME-Immun Inject / Junior».

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here